Recomienda este artículo a tus amigos:
Prescribing Hemodialysis: a Guide to Urea Modeling - Developments in Nephrology Thomas A. Depner Softcover Reprint of the Original 1st Ed. 1991 edition
Prescribing Hemodialysis: a Guide to Urea Modeling - Developments in Nephrology
Thomas A. Depner
What regulation shall we have for the operation? Shall a man transfuse he knows not what. to correct he knows not what. God knows how (l)? Dr. Henry Stubbs Royal College of Physicians circa 1670 If dialysis therapy were a new phannaceutical product being evaluated by the FDA now, it might not be approved for marketing. The recommended dose, its potential toxicity, the side effects of under-or over-dialysis as well as its efficacy have been the subject of very few studies. The high mortality rate associated with the treatment may raise a few eyebrows. That it is a life-saving modality of treatment is undoubtedly true for more than 100,000 patients in the United States and for more than a million patients world wide. Because dialysis has extended the lives of many people by a variable period of time, most nephrologists have "rested on their laurels" and did not vigorously pursue studies to optimize these treatments. But facts have a way of intruding in all our lives and the facts are that the overall mortality rate of dialysis patients in the United States is rising and stands close to 25% per year and is closer to 33% per year for patients between the ages of 65 and 74 (2). These mortality figures are considerably higher for age-adjusted dialysis populations in Europe and particu larly in Japan, and certainly for the age-adjusted nonnal population.
292 pages, biography
| Medios de comunicación | Libros Paperback Book (Libro con tapa blanda y lomo encolado) |
| Publicado | 26 de septiembre de 2011 |
| ISBN13 | 9781461288114 |
| Editores | Springer-Verlag New York Inc. |
| Páginas | 292 |
| Dimensiones | 155 × 235 × 17 mm · 449 g |
| Lengua | Inglés |